Calcium Dobesilate Monohydrate 500 MG (REDOB)

Calcium dobesilate effort on the walls of the small vessel and reduce their leakage and fragility also, this medicine also improves blood flow by decreasing thickness/ viscosity of blood.

Take it as per dose and duration recommended by the doctor

This medicine should be taken with food

Calcium dobesilate is useful in the treatment of piles and varicose veins

Inform your doctor if you are pregnant, breastfeeding, or planning a pregnancy

Inform your doctor if you notice an allergic reaction like nausea, skin rash, fever, and vomiting

Do not stop taking it suddenly without consulting your doctor first.

Some of the side effects are common and go away over time. But if you are experiencing the side effects are worsen or do not go away talk to your doctor immediately.

Fever

Headache

Vertigo

Chills

Nausea and vomiting

Skin rash

Diarrhea

Irregular heartbeats

Diabetic retinopathy

This medicine is used in the treatment of diabetic retinopathy, a complication of diabetes that might caused mild vision problems.

Hemorrhoids

This medicine is used in the treatment of hemorrhoids(swollen veins in the rectum and anus which might cause discomfort and bleeding).

Chronic venous insufficiency

This medicine is used in the treatment of chronic venous insufficiency, a condition where the valves in the leg veins are not working properly, causing blood to collect in these veins.

Microcirculation disorders

This medicine is used in the treatment of Microcirculation disorders, conditions characterized by the ineffective functioning of capillaries, venules, arterioles, etc.

Renal impairment

Calcium dobesilate must be used with caution in patients with a history of kidney disease and active kidney disease due to the increased risk of serving adverse effects. Report any unusual symptoms to the doctor promptly. Suitable dose adjustments or replacement with an appropriate alternative might be required based on the clinical condition.

Blood cell count

This medicine might lower the white blood cell count. Close monitoring of blood cell counts is essential while treating with this medicine. Do not start the treatment if the white blood cell count is less. Suitable dose adjustments or replacement with an appropriate alternative may be required based on the clinical condition.